These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6484216)

  • 21. Rioprostil and the gastric mucus-bicarbonate barrier.
    Guslandi M; Fasani R; Tittobello A
    Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of acid secretion and gastric lesions in rats by the prostanoid Ro 22-6923.
    Gaginella TS; Müller RK; Witt CG; Rosen P; Holland GW; Gallo-Torres H; Sullivan AC
    J Pharmacol Exp Ther; 1985 Jan; 232(1):202-7. PubMed ID: 2578188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of orally administered prostaglandins on gastric mucus secretion in the rat.
    Mahoney JM; Waterbury LD
    Prostaglandins Med; 1981 Aug; 7(2):101-7. PubMed ID: 7280123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of gastric mucus output by somatostatin in man.
    Johansson C; Aly A
    Eur J Clin Invest; 1982 Feb; 12(1):37-9. PubMed ID: 6121709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Secretion of gastric mucus following maximal pentagastrin stimulation].
    Zarzycki W; Badurski J; Jaworowska E; Sarosiek J
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(4):209-16. PubMed ID: 2433119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric secretion of platelet activating factor and precursors in healthy humans: effect of pentagastrin.
    Sobhani I; Denizot Y; Hochlaf S; Rigaud D; Vatier J; Benveniste J; Lewin MJ; Mignon M
    Gut; 1993 Aug; 34(8):1051-6. PubMed ID: 8174952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
    Guslandi M; Passaretti S; Tittobello A; Fasani R
    Clin Ther; 1986; 8(6):619-23. PubMed ID: 3098425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDL-646, a new synthetic E1-prostaglandin with local protective effects on the gastric mucosa.
    Spina G; Schiatti P; Selva D; Gallico L; Glässer A
    Prostaglandins; 1984 Aug; 28(2):158-71. PubMed ID: 6542241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.
    Playford RJ; Batten JJ; Freeman TC; Beardshall K; Vesey DA; Fenn GC; Baron JH; Calam J
    Gut; 1991 Nov; 32(11):1396-400. PubMed ID: 1752476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin-stimulated gastric mucus secretion in man.
    Domschke W; Domschke S; Hornig D; Demling L
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):292-4. PubMed ID: 358722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man.
    Caldara R; Guslandi M; Carbone M; Masci E; Cantù A; Ferrari C; Barbieri C; Dubini A
    Eur J Clin Pharmacol; 1987; 31(5):535-9. PubMed ID: 3830240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of prostaglandin E1, E2 and 16,16-dimethyl-E2 on gastric mucosal microcirculation and basal acid output in the rat.
    Holm-Rutili L
    Acta Physiol Scand; 1986 Jul; 127(3):313-21. PubMed ID: 3463127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M&B 28,767: a potent anti-secretory and anti-ulcer PG analogue. A comparative study with 16, 16' dimethyl PGE2 methylester.
    Banerjee AK; Christmas AJ; Crowshaw K; Heazell MA; Ivers-Read GC; Saunders LC; Wyatt D
    Life Sci; 1984 Dec; 35(25):2489-96. PubMed ID: 6513724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.
    Lenz HJ; Brozinsky S; Koss MA; Hogan DL; Scheinbaum ML; Isenberg JI
    Eur J Clin Pharmacol; 1986; 31(3):281-4. PubMed ID: 3792425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked suppression of stimulated gastric acid and pepsin secretion by enisoprost, a new PGE1 analogue.
    Howden CW; Burget DW; Silletti C; Van Eeden A; Tomkins KB; Hunt RH
    Aliment Pharmacol Ther; 1987 Aug; 1(4):305-13. PubMed ID: 2979675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prostaglandins on gastric acid and mucus secretion.
    Metsä-Ketelä T; Parantainen J; Vapaatalo H
    Adv Prostaglandin Thromboxane Res; 1980; 8():1553-6. PubMed ID: 6990727
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
    Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
    Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
    Onoda Y; Takido M; Magaribuchi T; Tamaki H
    Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the 'mucus-bicarbonate' barrier on rat fundic mucosa: the effects of luminal pH and a stable prostaglandin analogue.
    Ross IN; Turnberg LA
    Gut; 1983 Nov; 24(11):1030-3. PubMed ID: 6629112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.